- Market players should follow rules, Zagade tells IDMA meet o...

Indian protesters lift a balloon shaped like a pill during a demonstration against the Swiss drug manufacturer Novartis, in Mumbai on December 21, 2012. India's top court denied Monday a patent request by Swiss drug giant Novartis in a landmark ...

Suja Nair Shirodkar, Mumbai Top drug regulators from across the globe are expected to meet the Indian drug manufacturers and regulators in Mumbai to discuss and deliberate over export potential of the country, while addressing the regulatory issues ...

The new drug price control order (DPCO 2013) notified by the government of India evoked a mixed response from the industry and the pharmaceutical trade. The Indian Pharmaceutical Association (IPA) Tamil Nadu branch secretary J Jayaseelan said the ...

To address the issues related to drugs and other pharmaceutical products and also to ensure the quality of medicines manufactured and supplied, separate directorate of pharmacy (ED) should be established in each state under health departments.

NASHVILLE, Tenn., May 16 The Tennessee Attorney General issued the following news release: Generic drug maker Ranbaxy will pay Tennessee more than $5.5 million as part of a $500 million agreement resolving claims the company sold inferior drugs and ...

The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans. FORTUNE -- On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss ...

Attorney General Douglas F. Gansler announced today that Maryland has joined with 49 other states and the federal government in a $500 million settlement to resolve civil and criminal allegations that Ranbaxy, a generic pharmaceutical manufacturer ...

Novartis India headquarters in Mumbai. Photo:REUTERS Headlines have been trumpeting the Indian Supreme Court's decision to deny a new patent for the cancer drug Gleevec as an attack on intellectual property rights and a win for patients in need of ...

With the U.S. Food and Drug Administration (FDA) adhering to tougher import norms, a group of U.S.-based Indian-American scientists is now helping Indian pharmaceutical companies sharpen their knowledge and maintain competitiveness. These scientists ...